News | May 29, 2014

Dassault Systèmes Unveils 3-D Simulated Heart

The “Living Heart Project” attracts a multidisciplinary team of engineering and medical experts to help define the future diagnosis and treatment of the heart

May 29, 2014 — Dassault Systèmes the 3DEXPERIENCE Company, world leader in 3-D design software, 3-D Digital Mock Up and Product Lifecycle Management (PLM) solutions, unveiled the world’s first 3-D realistic simulation model of a whole human heart. Developed with a multidisciplinary team of heart experts to help combat cardiovascular disease, the “Living Heart Project” will launch the next frontier in diagnosing, treating and preventing heart conditions through personalized, 3-D virtual models.

According to recent research from the World Health Organization, 17.3 million people died from cardiovascular diseases globally in 2008, representing 30 percent of all global deaths. The American Heart Assn. report, “Forecasting the Future of Cardiovascular Disease in the United States,” believes the real total direct medical costs of cardiovascular disease will reach $818.1 billion over the next three decades.

At the center of the project is a 3-D heart model powered by Dassault Systèmes 3DEXPERIENCE platform’s realistic simulation applications. Simulation experts from Dassault Systèmes have used the latest advancements in simulation provided by the SIMULIA applications to develop a comprehensive 3-D heart model, capturing the electrical and mechanical behavior of the heart in the most realistic and vivid way.

Today, the lack of realistic 3-D human models limits researchers’ ability to predict device behavior in humans. The Living Heart Project has attracted a multidisciplinary community of medical researchers, practitioners, device manufacturers and industry regulators who will have access to 3-D computational models to accelerate the translation of research innovation into market-driven products and services.

Using echocardiogram, magnetic resonance imaging (MRI) and computed tomography (CT) scan images, along with cardiac research data, personalized 3-D heart simulations will soon allow medical professionals to better understand the behavior a patient’s heart without the need for additional invasive diagnostic procedures.

“We live in an exciting time with the capacity to simulate how a patient’s heart may respond to a wide range of interventions, sparing that individual and many others the uncertainties of their procedural outcome,“ stated James C. Perry, professor of pediatrics at UC San Diego and director of electrophysiology and adult CHD at Rady Children’s Hospital in San Diego. "This is true for those with congenital heart defects, whose lives necessarily include many cardiac procedures, but also for the larger population of people with heart failure, arrhythmias and other structural abnormalities. This technology is a huge advancement that will expedite the translation of our basic scientific understanding of cardiac function into practical applications that promote improved health and safety.“

The Living Heart Project is connecting many of the greatest minds in cardiovascular modeling and simulation to solve the toughest challenges using SIMULIA applications‘ leading capabilities for simulating complex nonlinear behavior to produce the most realistic and reliable results possible.

This realistic human heart simulation will not only become a valuable educational and translational tool to incite research innovation, but may also lead to accelerated regulatory approval cycles, reduced development costs for new and more personalized devices and will ultimately enable early diagnoses and improve treatment outcomes.

“The Living Heart Project is a leading example of the value and potential for realistic simulation to significantly impact healthcare in a positive way,“ noted Bill Murray, president and CEO, Medical Device Innovation Consortium. “The MDIC, a public-private partnership with the FDA, is proud to participate in these types of innovative efforts. The Living Heart Project is a model for how collaborations can work to advance regulatory science in the medical device industry and improve patient access to cutting-edge medical technology."

For more information: www.3ds.com

Related Content

Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
Overlay Init